Table 1.
Characteristic | Study Population |
Insulin Status |
p | ||||
---|---|---|---|---|---|---|---|
No insulin prescription |
Insulin prescription within 1 year of cancer diagnosis |
||||||
n | % | n | % | n | % | ||
Total | 334 | 296 | 88.6 | 38 | 11.4 | ||
Age at cancer diagnosis (years) | 0.23 | ||||||
18–24 | 55 | 16.5 | 48 | 16.2 | 7 | 18.4 | |
25–29 | 52 | 15.6 | 50 | 16.9 | 2 | 5.3 | |
30–34 | 103 | 30.8 | 92 | 31.1 | 11 | 28.9 | |
35–39 | 124 | 37.1 | 106 | 35.8 | 18 | 47.4 | |
Mean (SD) | 31.4 | (5.7) | 31.3 | (5.7) | 32.2 | (5.9) | 0.40 |
BMI | 0.18 | ||||||
Underweight/normoweight (<25 kg/m2) | 143 | 42.8 | 131 | 44.3 | 12 | 31.6 | |
Overweight (25–29.99 kg/m2) | 91 | 27.2 | 81 | 27.4 | 10 | 26.3 | |
Obese (30+ kg/m2) | 100 | 29.9 | 84 | 28.4 | 16 | 42.1 | |
Mean (SD), kg/m2 | 27.9 | (7.4) | 27.4 | (7.0) | 31.5 | (9.8) | 0.001 |
Sex | 0.14 | ||||||
Female | 204 | 61.1 | 185 | 62.5 | 19 | 50.0 | |
Male | 130 | 38.9 | 111 | 37.5 | 19 | 50.0 | |
Race | — | ||||||
White | 306 | 91.6 | 270 | 91.2 | 36 | 94.7 | |
Other/unknown | 28 | 8.4 | 26 | 8.8 | 2 | 5.3 | |
Marital status | 0.23 | ||||||
Married | 207 | 62.0 | 186 | 62.8 | 21 | 55.3 | |
Unmarried | 116 | 34.7 | 99 | 33.4 | 17 | 44.7 | |
Unknown | 11 | 3.3 | 11 | 3.7 | 0 | 0.0 | |
Smoking history | 0.64 | ||||||
Never smoker | 247 | 74.0 | 220 | 74.3 | 27 | 71.1 | |
Ever smokera | 86 | 25.7 | 75 | 25.3 | 11 | 28.9 | |
Unknown | 1 | 0.3 | 1 | 0.3 | 0 | 0.0 | |
State of residence | 0.46 | ||||||
Utah | 242 | 72.5 | 213 | 72.0 | 29 | 76.3 | |
Idaho | 40 | 12.0 | 36 | 12.2 | 4 | 10.5 | |
Wyoming | 19 | 5.7 | 18 | 6.1 | 1 | 2.6 | |
Nevada | 21 | 6.3 | 17 | 5.7 | 4 | 10.5 | |
Other | 12 | 3.6 | 12 | 4.1 | 0 | 0.0 | |
Type 2 diabetes | <0.001 | ||||||
None | 319 | 95.5 | 288 | 97.3 | 31 | 81.6 | |
Yes | 15 | 4.5 | 8 | 2.7 | 7 | 18.4 | |
Glucocorticoid prescriptionb | 0.48 | ||||||
None | 98 | 29.3 | 85 | 28.7 | 13 | 34.2 | |
Yes | 236 | 70.7 | 211 | 71.3 | 25 | 65.8 | |
AJCC clinical stage | 0.93 | ||||||
I | 79 | 23.7 | 74 | 25.0 | 5 | 13.2 | |
II | 43 | 12.9 | 39 | 13.2 | 4 | 10.5 | |
III | 30 | 9.0 | 28 | 9.5 | 2 | 5.3 | |
IV | 22 | 6.6 | 20 | 6.8 | 2 | 5.3 | |
Not specified/Not applicablec | 160 | 47.9 | 135 | 45.6 | 25 | 65.8 | |
Cancer sequence | 0.86 | ||||||
Only 1 primary | 310 | 92.8 | 275 | 92.9 | 35 | 92.1 | |
First of 2+ primaries | 24 | 7.2 | 21 | 7.1 | 3 | 7.9 | |
Chemotherapy | 0.59 | ||||||
None/unknown | 172 | 51.5 | 154 | 52.0 | 18 | 47.4 | |
Yes | 162 | 48.5 | 142 | 48.0 | 20 | 52.6 | |
Surgery | 0.96 | ||||||
None/unknown | 27 | 8.1 | 24 | 8.1 | 3 | 7.9 | |
Yes | 307 | 91.9 | 272 | 91.9 | 35 | 92.1 | |
Hormone therapy | 0.18 | ||||||
None/unknown | 262 | 78.4 | 229 | 77.4 | 33 | 86.8 | |
Yes | 72 | 21.6 | 67 | 22.6 | 5 | 13.2 | |
Immunotherapy | 0.10 | ||||||
None/unknown | 300 | 89.8 | 263 | 88.9 | 37 | 97.4 | |
Yes | 34 | 10.2 | 33 | 11.1 | 1 | 2.6 | |
Radiation therapy | 0.17 | ||||||
None/unknown | 218 | 65.3 | 197 | 66.6 | 21 | 55.3 | |
Yes | 116 | 34.7 | 99 | 33.4 | 17 | 44.7 |
p values do not include unknown or not applicable values.
Ever smoker includes current and former smokers.
First glucocorticoid prescription 1+ days after cancer diagnosis.
Brain and other nervous system cancers do not have applicable staging information.
AJCC, American Joint Committee on Cancer; BMI, body mass index, SD, standard deviation.